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Our great international community of obstetricians and
perinatologists is holding its family get-together in
Berlin again. Berlin is in the true sense of the word a
meeting place ful l of nostalgia - the greek word nostos
means f lhome-coming f l and algos means "pains11, so
"homesick for the good old days11.
It was here in Berlin 15 years ago that the 1st
International Meeting of the then active perinatologists
took place from 28th to 30th March 1968 within the
framework of the 1st European Congress of Perinatal
Medicine. From the number of participants - 1 ,287 took
part - it is clear to see how much interest already
existed at that time.
But we should not look at the Berlin meetings only in a
nostalgic way; during the course of the first congress
mentioned above, the European Association of Perinatal
Medicine was founded and has met every other year since
1968 - eight times in all - in various European cities
under the presidency of outstanding colleagues.
Independent of these, 10 German congresses dealing with
this important and new field of medicine have taken
place here in Berlin. These congresses - 18 in all
held in Europe and Berlin have offered the most highly
concentrated impulses for continuing research and have
conveyed medical and clinical knowledge from all over
the world. These facts are highly encouraging and
stimulating both for you as participants and for us, the
organizers.
It is not our wish that the International Berlin Meeting
- affil iated to the German Congress for four years
should become a big event. Its purpose is rather to give
all foreign colleagues sympathizing with the scientific
activities going on in Berlin, the opportunity of
visiting the meantime classical old home of perinatal
medicine, and so to renew old memories and also at the
same time to hear about the latest scientific findings
first hand from*the abundant contributions to the great
11th German Congress taking place here now, and also
from the contributions of guests invited from overseas.
With this in mind I wish every success to the 3rd
International Berlin Meeting and a pleasant and
informative stay in Berlin to all the participants.
CLINICAL ROLE OF PROSTAGLANDINS IN MODERN OBSTETRICS
Moderator: Fritz Fuchs, M.D. , Cornell University Medical College,
New York, New York
Panelists: Andrew A. Calder, M.D. , University Department of Ob-
stetrics and Gynaecology, Royal Infirmary, Glasgow,
Scotland
Klaus Goeschen, M.D. , Arbeitsgruppe Perinatale Medizin,
Freie Universität Berlin
. Marc J .N.C. Keirse, M.D. , Department of Obstetrics and
Gynecology, University of Leiden, The Netherlands
F. Fuchs: Physiological Role of Prostaglandins in Human Parturi-
tion.
The ability of prostaglandins (PG) E^, £2, and F2a to stimulate
the uterus to contract at any time of gestation suggest a role in
the physiological activation of the uterus in parturition. This
hypothesis is supported by the fact that prostaglandin synthetase
inhibitors can inhibit preterm labor and delay parturition, by the
marked rise in the amniotic fluid levels of PGE£ and PGF2a during
term labor, and by the rise in the circulating levels of the PGF2a
metabolite 13,14-dihydro-15-keto-PGF2a (PGFM) during advanced labor,
All uterine tissues have the capacity to synthetize PCs, al-
though the spectrum varies from tissue to tissue, and no marked
changes occur at the onset of labor. It seems clear that the capa-
city to produce PCs from endogenous substrates exists long before
labor begins and substrate availability is not a limiting factor.
We must assume that under in vivo conditions, prostanoid synthesis
is kept at bay by inhibitory factors which are withdrawn during
parturition, or that stimulatory factors increase the rate of pro-
duction of PCs during labor. We have found that oxytocin is a po-
tent stimulator of prostaglandin synthesis. It is an attractive
hypothesis that a fetal signal initiates labor, a belief held al-
ready by Hippocrates. We propose that fetal oxytocin provides such
a signal by stimulation of the prostanoid production in uterine
tissues which then enhances the contractions elicited by oxytocin.
Besides PGE2 and PGF2a, prostacyclin and to a lesser degree throm-
boxane and PGD2 are formed within the human uterus. The decidua
may be an important site of PG synthesis and its proximity to the
myometrium suggests that oxytocic PCs from this tissue could play
an important role in myometrial activation. Both myometrium and
decidua contain oxytocin receptors, with the highest concentrations
in early labor.
Prostaglandins, together with relaxin, estrogens and progester-
one participate in the control of cervical ripening which is neces-
sary for successful parturition.
The evidence suggests that oxytocin initiates labor and that the
prostaglandins interact in the maintenance of labor, expulsion of
fetus and placenta, and the post partum hemostasis.
A.A. Calder: Comparison of Various Methods of Induction of Cervi-
cal Ripening and Labour, Including Prostaglandins,
Oxytocin, Oestradiol and Mechanical Means.
Human parturition is not the rather sudden phenomenon it may
sometimes appear, but a gradual evolution of uterine contractility
and cervical ripening, occurring in concert over several weeks at
the end of pregnancy. When induction of labour becomes necessary
for the safe delivery of the infant, attention must be paid to the
status of the cervix; methods to accelerate ripening of the cervix
will greatly increase the success of induction of labour and reduce
the need of surgical intervention. There is no better indicator
of the likely response to induction of labour than the condition
of the cervix, the dilatation, effacement and compliance of the
cervix. If the cervix is not ripe then induction of labour without
first taking steps to ripen the cervix may lead the mother, the fe-
tus and the obstetrician into trouble.
(1) Mechanical methods, often of bizarre character have been pro-
posed but are mostly of historical interest with the exception of
intracervical balloons and laminaria which result in release of
prostaglandins as do amniotomy and even sweeping of the membranes.
(2) Oxytocin, the most commonly used agent for induction, does have
some effect on cervical ripening, but its effect is greatly en-
hanced by amniotomy. The primigravida with an unripe cervix will
respond poorly to oxytocin infusion, if amniotomy cannot be done.
(3) Prostaglandins have largely compensated for the deficiencies of
oxytocin. The method of choice is direct application of PCs toward
the cervix (extra-amniotically, endocervically, or vaginally) in a
gel or pessary. When the cervix is ripe, amniotomy and/or oxytocin
infusion can be used to enhance uterine contractions.
(4) Other hormones, such as oestrogens and relaxin have been used
for cervical ripening. They may be less effective but do not seem
to cause uterine contractions, allowing ripening and induction to
be accomplished separately.
K. Goeschen: Comparison of Various Applications of Prostaglandin
E2 for Cervical Ripening.
It is important to determine the best form of application, the
optimal doses, the best frequency of application, and the best way
to avoid or treat excessive uterine activity. PGE2 can be given as
infusion, as endocervical injection dissolved in a gel, as applica-
tion in a cervical cap or as injection through a cervical balloon
catheter. Our studies have shown that the simplest and most practi-
cal application is 400 yg PGE2 dissolved in gel endocervically
every 8 hours. The best results were found in the catheter group
but the difference was small and the ease of injection of a gel
with a blunt cannula made this form of application the preferred
method. In more than half of the cases, a single application was
sufficient. If more than one application was required, an interval
of 8 hours was found to be best. Doubling the dose to 800 yg did
not improve the results but led to a higher incidence of undesirable
uterine activity.
Simultaneous administration of a betamimetics did not reduce the
ripening effect of the PGE2 application. This supports the hypo-
thesis that PGE2 applied endocervically exerts its effect locally
and not by enhancement of the uterine activity.
The recommended procedure for cervical ripening is:
(1) Endocervical injection of 400 yg PGE2 in gel.
(2) If ripening has progressed by 8 points in score, induction of
labor by oxytocin and/or amniotomy.
(3) If the score is less than 8, a 2nd inj. of 400 yg PGE2 gel.
(4) If a third application is necessary, place a 15 ml balloon
catheter in the cervix for injection of 400 yg PGE2 gel.
(5) If uterine contractions are undesirable, use tocolytic agents
simultaneously.
M.J .N.C. Keirse: Comparison of Various Prostaglandins for Indue-
tion of Abortion, Missed Labour and for Treat-
ment of Post-Partum Atony.
In the first trimester, none of the known PG regimens can match
the convenience and acceptability of vacuum aspiration for termin-
ation of pregnancy. Moreover, the use of PCs do not eliminate the
need for aspiration since the incidence of incomplete abortion is
considerable, though depending on method and gestation age. Se-
lective use of PCs to lower the cervical resistance in women with
a rigid cervix is an advantage, though there is disagreement about
the choice of PG and the dosage. Vaninal suppositories of 0.5-
1.0 mg of 16,16-dimenthyl PGE2 analogues, intramuscular injection
of 250-500 yg sulprostone or intracervical injection of 25 yg sul-
prostone has been recommended.
In second trimester termination a number of applications have
been studied. Systemic application of natural PCs is obsolete.
Extraamniotic instillation of 200 yg PGE2 or 750 yg PGF2 every
2 hours or by continuous infusion has a high success rate and low
incidence of side effects but oxytocin may be needed as adjuvant
treatment. Many analogues have been tested; at the moment sulpro-
stone appears to be the best choice; 0.5 mg i.m. every 4 hrs,
1.5 mg i.v. over 6 hrs or 1.0 mg i.v. over 10 hrs seem to be use-
ful schedules.
For the management of antepartum fetal death the natural PCs
have more disadvantages than some of the newer analogues. Intra-
muscular administration of 250 yg of 15-methyl-PGF2a every 2 hours
or 500 yg sulprostone every 4-6 hours is very effective; reducing
the dose to half may yield almost as good results.
Post partum atony is a dreaded complication where the use of
PCs may be life-saving. The reported experience is limited, but
the available data suggest that intramyometrial injection of 250
yg sulprostone, 125 yg 15-methyl-PGF2a or 1.0 mg PGF2a may control
severe postpartum bleeding due to inability of the uterus to con-
tract spontaneously or respond to oxytocin or ergot preparations.
The subsequent discussion dealt with the problems raised by the
panelists.
